AAP
CME icon

Arax Advisory Partners’s CME Group CME Stock Holding History

Arax Advisory Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.5M Buy
133,725
+97,487
+269% +$27M 0.2% 100
2026
Q1 		$10.7M Sell
36,238
-221
-0.6% -$65.6K 0.3% 72
2025
Q4 		$9.96M Sell
36,459
-6,498
-15% -$1.77M 0.29% 75
2025
Q3 		$11.6M Buy
42,957
+8,410
+24% +$2.29M 0.17% 90
2025
Q2 		$9.52M Buy
34,547
+32,730
+1,801% +$8.9M 0.44% 51
2025
Q1 		$482K Buy
1,817
+171
+10% +$42.2K 0.03% 323
2024
Q4 		$382K Buy
1,646
+1,623
+7,057% +$373K 0.02% 350
2024
Q3 		$5.05K Buy
23
+6
+35% +$1.24K ﹤0.01% 1709
2024
Q2 		$3.31K Hold
17
– – ﹤0.01% 1781
2024
Q1 		$3.62K Hold
17
– – ﹤0.01% 962
2023
Q4 		$3.5K Sell
17
-3
-15% -$640 ﹤0.01% 952
2023
Q3 		$3.92K Sell
20
-6
-23% -$1.19K ﹤0.01% 924
2023
Q2 		$4.73K Buy
26
+3
+13% +$554 ﹤0.01% 876
2023
Q1 		$4.49K Buy
23
+3
+15% +$542 ﹤0.01% 874
2022
Q4 		$3.38K Sell
20
-2
-9% -$348 ﹤0.01% 872
2022
Q3 		$4K Buy
22
+13
+144% +$2.57K ﹤0.01% 846
2022
Q2 		$2K Buy
+9
New +$1.91K ﹤0.01% 933
2022
Q1 		– Sell
-5
Closed -$1K – 1160
2021
Q4 		$1K Buy
+5
New +$1.1K ﹤0.01% 980
2018
Q3 		– Sell
-37
Closed -$6K – 638
2018
Q2 		$6K Buy
37
+4
+12% +$653 ﹤0.01% 377
2018
Q1 		$5K Buy
33
+15
+83% +$2.39K ﹤0.01% 370
2017
Q4 		$2K Hold
18
– – ﹤0.01% 414
2017
Q3 		$2K Sell
18
-52
-74% -$6.57K ﹤0.01% 410
2017
Q2 		$9K Buy
70
+57
+438% +$6.82K ﹤0.01% 354
2017
Q1 		$1K Hold
13
– – ﹤0.01% 482
2016
Q4 		$1K Buy
+13
New +$1.45K ﹤0.01% 514

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Arax Advisory Partners's CME Position: Q2 2026 in Review

Arax Advisory Partners increased its CME Group (CME) stake by 269% in Q2 2026, buying an estimated $27M and bringing the position to 133,725 shares worth $29.5M. The position accounts for 0.2% of the portfolio, ranked #100.

Arax Advisory Partners first reported a position in CME in Q4 2016 and has held it in 25 quarters since. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Arax Advisory Partners held 133,725 shares of CME Group worth $29.5M as of Q2 2026.
  • Arax Advisory Partners bought 97,487 CME Group shares in Q2 2026, an estimated $27M.
  • CME Group made up 0.2% of Arax Advisory Partners's portfolio in Q2 2026, its #100 holding.
  • Arax Advisory Partners first reported a position in CME Group in Q4 2016 and has held it in 25 quarters since.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.